HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells
2022 · BMC Cancer · 60 citations
https://doi.org/10.1186/s12885-022-09675-1
S
Suyanee Thongchot
Siriraj Hospital(TH)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
68
Papers
1.0K
Citations
19
h-index
28
i10-index
Suyanee Thongchot is an academic researcher from Siriraj Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & CAR-T cell therapy research. The author has an h-index of 19, co-authored 58 publications.
ORCID: 0000-0003-3159-0464Papers by this author
worksCancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse
2021 · Cancers · 53 citations
https://doi.org/10.3390/cancers13092134
Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways
2023 · Breast Cancer Research · 46 citations
https://doi.org/10.1186/s13058-023-01684-7
Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells
2018 · PLoS ONE · 34 citations
https://doi.org/10.1371/journal.pone.0199827
Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma
2022 · Frontiers in Pharmacology · 27 citations
https://doi.org/10.3389/fphar.2022.897368
Cellular localization of nucleolin determines the prognosis in cancers: a meta-analysis
2022 · Journal of Molecular Medicine · 21 citations
https://doi.org/10.1007/s00109-022-02228-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat